
...

By Melissa Fleur Afshar
Reporter
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
Gastrointestinal cancers are expected to double worldwide by 2050, with pancreatic and colorectal cancers driving the sharpest increases.
The projections show the growing impact of lifestyle-related risk factors and gaps in early detection—while pointing to clear steps people can take now to reduce their risk.
“These rising cancer rates are expected worldwide, and large-scale efforts need to be made to encourage lifestyle changes and develop screening programs to reduce them,” Dr. Ju Dong Yang, medical director of the Liver Cancer Program at Cedars-Sinai and a co-corresponding author of the study, said in a statement.
Read More on Health
The analysis, conducted through a multicenter study co-led by Cedars-Sinai, projects substantial increases in diagnoses and deaths from pancreatic, colorectal, liver, esophageal and gastric cancers over the next 24 years.
Experts at Cedars-Sinai say many of these cancers are closely tied to preventable risk factors and are often diagnosed too late to be cured by treatment.

...
A Growing Global Cancer Burden
The study’s findings show that pancreatic cancer diagnoses and colorectal cancer deaths are expected to rise the most by 2050.
Esophageal and liver cancer diagnoses and deaths are also projected to increase worldwide.
Together, these cancers represent a growing share of global cancer mortality. Many develop silently, with few symptoms until the disease is advanced, making prevention and early detection critical to improving survival.
Liver Cancer: A Preventable Disease
Yang said up to 70 percent of liver cancers could be prevented through lifestyle changes.
While hepatitis B and C were once the dominant causes of liver cancer in the U.S., they are increasingly being overtaken by metabolic dysfunction-associated steatotic liver disease, or MASLD.
“MASLD is emerging as a leading cause of liver cancer in Western countries, including the U.S.,” Yang said.
The condition involves fat buildup in the liver and is linked to obesity, diabetes, high cholesterol and high blood pressure.
Controlling these all risk factors can significantly reduce risk, Yang said. He also noted that screening remains underused: only about 20 percent of people in the U.S. with cirrhosis from hepatitis or other chronic liver diseases receive liver cancer screening.
As a result, only about 30 percent of liver cancers are detected early enough to be cured.
Esophageal and Gastric Cancers
Lifestyle factors and limited screening also play a major role in esophageal and gastric cancers, said Dr. Alexandra Gangi, director of the Gastrointestinal Tumor Program at Cedars-Sinai.
“These tumors cause few symptoms before the cancer has spread—and they tend to spread rapidly,” Gangi said in a statement.
She urged people to focus on preventable risks such as obesity, tobacco and alcohol use, and poor diet. Those with chronic acid reflux, gastritis or a family history of these cancers should discuss screening options with their doctor.
Colorectal Cancer: Screening Saves Lives
Colorectal cancer is highly treatable when caught early, but deadly when diagnosed late, said Dr. Alessio Pigazzi, director of the Division of Colorectal Surgery.
“Late diagnosis makes colorectal cancer highly lethal, while early diagnosis leads to very high cure rates,” Pigazzi said in a statement.
He emphasized that everyone should be screened by age 45, with earlier screening for those with a family history. Diets high in fiber and low in sugars and animal fats, regular exercise, and attention to warning signs such as rectal bleeding or unexplained bowel changes can further lower risk.
Pancreatic Cancer and What’s Next
Pancreatic cancer remains one of the hardest GI cancers to detect early, with about half of patients diagnosed after the disease has spread, Dr. Arsen Osipov, medical director of Pancreatic Cancer and Multidisciplinary Programs and Integration, in a statement accompanying the findings.
Recent advances, including blood-based “liquid biopsy” tests and structured screening for people with strong genetic risk, are improving early detection, he said.
Osipov recommended lifestyle changes similar to those for other GI cancers and advised people with chronic pancreatitis or a family history of pancreatic cancer to consider genetic counseling.
Looking ahead, Cedars-Sinai researchers are advancing blood-based biomarkers, precision radiotherapy and personalized, biology-driven treatments, said Dr. Katelyn Atkins and Dr. Robert Figlin.
Together, these efforts aim not only to improve survival, but also to preserve quality of life—while reinforcing the importance of prevention and early detection as cancer rates continue to rise.
Do you have a tip on a health story that Newsweek should be covering? Do you have a question about gastronintestinal cancers? Let us know via health@newsweek.com.
Reference
Danpanichkul, P., Pang, Y., Tothanarungroj, P., Dejvajara, D., Kim, D., Saokhieo, P., Suparan, K., Muthiah, M. D., Duangsonk, K., Bernal, D. O., Lui, R. N., Wijarnpreecha, K., Abou-Alfa, G. K., Wallace, M. B., Roberts, L. R., Singal, A. G., & Yang, J. D. (2026). Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries. Cancer, 132(1). https://doi.org/10.1002/cncr.70245
View 0 Comments
Submit Correction
View Editorial & AI Guidelines